Leucid Bio Ltd
Leucid Bio Ltd
Trading as: Leucid Bio
#09331486 • Active
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part of Leucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.
Founded: 27/11/2014
Industries: Research and experimental development on biotechnology
Website: https://leucid.com
Financial Snapshot
Last accounts made up to 30 June 2024
Next accounts due 31 March 2026 (10 months)
Cash in Bank £4.97m
↓ -49%
Total Liabilities £1.14m
↑ 128%
Employees 20
↑ 100%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Heikki Lanckriet | Director | 13/02/2025 | Belgian | 48 years |
| Filippo Joseph Petti | Chief Executive Officer | 17/07/2023 | American | 49 years |
| Martin Henry Diggle | Director | 24/06/2021 | British | 63 years |
| Ian Alexander Francis Miscampbell | Fund Manager | 24/06/2021 | British | 63 years |
| Peter Michael Finan | Venture Partner | 26/06/2017 | British | 57 years |
Role:
Director
Appointed:
13/02/2025
Nationality:
Belgian
Age:
48 years
Role:
Chief Executive Officer
Appointed:
17/07/2023
Nationality:
American
Age:
49 years
Role:
Director
Appointed:
24/06/2021
Nationality:
British
Age:
63 years
Role:
Fund Manager
Appointed:
24/06/2021
Nationality:
British
Age:
63 years
Role:
Venture Partner
Appointed:
26/06/2017
Nationality:
British
Age:
57 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality | |
|---|---|---|---|---|
| No active PSCs found | ||||
No active PSCs found
Financial Accounts
| Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
2 charges registered
Hsbc Innovation Banking Outstanding
Created 21/08/2023#093314860002 Negative Pledge
Silicon Valley Bank UK Satisfied
Created 02/08/2022#093314860001 Negative Pledge
Properties
No property information available
Grants
No grant information available
Group Structure
No group structure information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 07/04/2025 | Accounts | Accounts With Accounts Type Small | View (13 pages) |
| 24/03/2025 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 06/03/2025 | Capital | Capital Allotment Shares | View (4 pages) |
| 05/03/2025 | Capital | Capital Allotment Shares | View (5 pages) |
| 27/02/2025 | Incorporation | Memorandum Articles | View (51 pages) |
| 27/02/2025 | Resolution | Resolution | View (3 pages) |
| 17/12/2024 | Confirmation Statement | Confirmation Statement With Updates | View (5 pages) |